Cargando…

Challenges in HIV Vaccine Research for Treatment and Prevention

Many attempts have been made or are ongoing for HIV prevention and HIV cure. Many successes are in the list, particularly for HIV drugs, recently proposed also for prevention. However, no eradication of infection has been achieved so far with any drug. Further, a residual immune dysregulation associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ensoli, Barbara, Cafaro, Aurelio, Monini, Paolo, Marcotullio, Simone, Ensoli, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157563/
https://www.ncbi.nlm.nih.gov/pubmed/25250026
http://dx.doi.org/10.3389/fimmu.2014.00417
_version_ 1782333900683476992
author Ensoli, Barbara
Cafaro, Aurelio
Monini, Paolo
Marcotullio, Simone
Ensoli, Fabrizio
author_facet Ensoli, Barbara
Cafaro, Aurelio
Monini, Paolo
Marcotullio, Simone
Ensoli, Fabrizio
author_sort Ensoli, Barbara
collection PubMed
description Many attempts have been made or are ongoing for HIV prevention and HIV cure. Many successes are in the list, particularly for HIV drugs, recently proposed also for prevention. However, no eradication of infection has been achieved so far with any drug. Further, a residual immune dysregulation associated to chronic immune activation and incomplete restoration of B and T cell subsets, together with HIV DNA persistence in reservoirs, are still unmet needs of the highly active antiretroviral therapy, causing novel “non-AIDS related” diseases that account for a higher risk of death even in virologically suppressed patients. These “ART unmet needs” represent a problem, which is expected to increase by ART roll out. Further, in countries such as South Africa, where six millions of individuals are infected, ART appears unable to contain the epidemics. Regretfully, all the attempts at developing a preventative vaccine have been largely disappointing. However, recent therapeutic immunization strategies have opened new avenues for HIV treatment, which might be exploitable also for preventative vaccine approaches. For example, immunization strategies aimed at targeting key viral products responsible of virus transmission, activation, and maintenance of virus reservoirs may intensify drug efficacy and lead to a functional cure providing new perspectives also for prevention and future virus eradication strategies. However, this approach imposes new challenges to the scientific community, vaccine developers, and regulatory bodies, such as the identification of novel immunological and virological biomarkers to assess efficacy end-points, taking advantage from the natural history of infection and exploiting lessons from former trials. This review will focus first on recent advancement of therapeutic strategies, then on the progresses made in preventative approaches, discussing concepts, and problems for the way ahead for the development of vaccines for HIV treatment and prevention.
format Online
Article
Text
id pubmed-4157563
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-41575632014-09-23 Challenges in HIV Vaccine Research for Treatment and Prevention Ensoli, Barbara Cafaro, Aurelio Monini, Paolo Marcotullio, Simone Ensoli, Fabrizio Front Immunol Immunology Many attempts have been made or are ongoing for HIV prevention and HIV cure. Many successes are in the list, particularly for HIV drugs, recently proposed also for prevention. However, no eradication of infection has been achieved so far with any drug. Further, a residual immune dysregulation associated to chronic immune activation and incomplete restoration of B and T cell subsets, together with HIV DNA persistence in reservoirs, are still unmet needs of the highly active antiretroviral therapy, causing novel “non-AIDS related” diseases that account for a higher risk of death even in virologically suppressed patients. These “ART unmet needs” represent a problem, which is expected to increase by ART roll out. Further, in countries such as South Africa, where six millions of individuals are infected, ART appears unable to contain the epidemics. Regretfully, all the attempts at developing a preventative vaccine have been largely disappointing. However, recent therapeutic immunization strategies have opened new avenues for HIV treatment, which might be exploitable also for preventative vaccine approaches. For example, immunization strategies aimed at targeting key viral products responsible of virus transmission, activation, and maintenance of virus reservoirs may intensify drug efficacy and lead to a functional cure providing new perspectives also for prevention and future virus eradication strategies. However, this approach imposes new challenges to the scientific community, vaccine developers, and regulatory bodies, such as the identification of novel immunological and virological biomarkers to assess efficacy end-points, taking advantage from the natural history of infection and exploiting lessons from former trials. This review will focus first on recent advancement of therapeutic strategies, then on the progresses made in preventative approaches, discussing concepts, and problems for the way ahead for the development of vaccines for HIV treatment and prevention. Frontiers Media S.A. 2014-09-08 /pmc/articles/PMC4157563/ /pubmed/25250026 http://dx.doi.org/10.3389/fimmu.2014.00417 Text en Copyright © 2014 Ensoli, Cafaro, Monini, Marcotullio and Ensoli. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Ensoli, Barbara
Cafaro, Aurelio
Monini, Paolo
Marcotullio, Simone
Ensoli, Fabrizio
Challenges in HIV Vaccine Research for Treatment and Prevention
title Challenges in HIV Vaccine Research for Treatment and Prevention
title_full Challenges in HIV Vaccine Research for Treatment and Prevention
title_fullStr Challenges in HIV Vaccine Research for Treatment and Prevention
title_full_unstemmed Challenges in HIV Vaccine Research for Treatment and Prevention
title_short Challenges in HIV Vaccine Research for Treatment and Prevention
title_sort challenges in hiv vaccine research for treatment and prevention
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157563/
https://www.ncbi.nlm.nih.gov/pubmed/25250026
http://dx.doi.org/10.3389/fimmu.2014.00417
work_keys_str_mv AT ensolibarbara challengesinhivvaccineresearchfortreatmentandprevention
AT cafaroaurelio challengesinhivvaccineresearchfortreatmentandprevention
AT moninipaolo challengesinhivvaccineresearchfortreatmentandprevention
AT marcotulliosimone challengesinhivvaccineresearchfortreatmentandprevention
AT ensolifabrizio challengesinhivvaccineresearchfortreatmentandprevention